Nektar Therapeutics Annual Income Statement (NASDAQ:NKTR)

Add to My Stocks
$22.17 $0.51 (2.35%) NKTR stock closing price Jul 20, 2017 (Closing)

NKTR stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Nektar Therapeutics stock price. In the income statement, an investor can look at important parameters like revenue, gross profits, net profits, and EPS basic to gain deeper insights. Like any other income statement, the NKTR income statement also itemizes revenue, operating expenses, and profits for a quarter or year and reflects a YoY revenue decline of $65.35M when compared to the same period in the past. Along with Nektar Therapeutics assets and Nektar Therapeutics free cash flow, profits as shown in profit and loss statement give key insights about the business. The profits have decreased from $-81.17M YoY and 2016 revenue is $165.43M. Nektar Therapeutics revenue for 2016 is $165.43M. View revenue and profit details for latest and last 10 financial years.

show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Nektar Therapeutics Net Sales or Revenues
Cost Of Goods Sold (COGS)30.21M34.1M28.53M38.5M30.42M21.89M25.66M30.94M35.03M147.51M
Nektar Therapeutics Gross Profit
Research & Development Expense203.8M182.78M147.73M190.01M148.67M126.76M108.06M95.1M154.41M153.57M
Selling General & Admin Expense44.27M43.26M40.92M40.53M43.28M46.76M53.56M41M-16.61M56.33M
Income Before Depreciation Depletion Amortization-112.85M-29.37M-16.48M-120.13M-141.2M-123.93M-28.25M-95.13M-82.65M-84.4M
Depreciation Depletion Amortization---------0.94M
Non Operating Income2.38M-12.39M0.81M1.12M3.29M1.2M2.37M4.53M62.7M72.53M
Interest Expense42.18M38.9M38.75M40.76M33.54M10.22M11.17M12.17M15.19M18.63M
Nektar Therapeutics Pretax Income
Provision for Income Taxes0.87M0.5M-0.51M2.24M0.4M1.01M0.88M-0.25M-0.8M1.3M
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-153.52M-81.17M-53.91M-162.01M-171.85M-133.97M-37.93M-102.51M-34.33M-32.76M
Extraordinary Items & Discontinued Operations----------
Nektar Therapeutics Net Income (Profit/Loss)
Average Shares used to compute Diluted EPS139.6M132.46M126.87M115.73M114.82M112.94M94.08M92.77M92.41M91.88M
Average Shares used to compute Basic EPS139.6M132.46M126.87M115.73M114.82M112.94M94.08M92.77M92.41M91.88M
Income Before Nonrecurring Items-153.52M-81.18M-53.92M-162.01M-170.77M-133.98M-25.71M-102.52M-154.01M-83.29M
Income from Nonrecurring Items-----1.09M--12.23M-69.57M50.53M
Nektar Therapeutics Earnings Per Share Basic Net
Nektar Therapeutics Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-1.10-0.61-0.42-1.40-1.49-1.19-0.27-1.11-1.67-0.91
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Income statement for another ticker

The key things to look for in an income statement while doing Nektar Therapeutics stock analysis are:
  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth (See: Nektar Therapeutics revenue chart) implies that the company is growing, which has not been the case with Nektar Therapeutics. One must stay away from stocks whose revenues are declining.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-153.52M for Nektar Therapeutics for 2016. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Nektar Therapeutics historical stock prices to check how the price has moved with time. .

Nektar Therapeutics Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
Operating margin
Net profit margin
Dividend yield